Comment
. 2007 Jan 11;356(2):189-90; author reply 190-1.
doi: 10.1056/NEJMc062409.
Refining prognosis in non-small-cell lung cancer
- PMID: 17215540
- DOI: 10.1056/NEJMc062409
Item in Clipboard
Comment
Refining prognosis in non-small-cell lung cancer
N Engl J Med.
.
No abstract available
Comment on
-
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.N Engl J Med. 2006 Aug 10;355(6):570-80. doi: 10.1056/NEJMoa060467. N Engl J Med. 2006. Retraction in: N Engl J Med. 2011 Mar 24;364(12):1176. doi: 10.1056/NEJMc1101915. PMID: 16899777 Retracted.
Similar articles
-
Refining prognosis in non-small-cell lung cancer.N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1. N Engl J Med. 2007. PMID: 17225285 No abstract available.
-
Refining prognosis in non-small-cell lung cancer.N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1. N Engl J Med. 2007. PMID: 17225287 No abstract available.
-
Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence.Cancer. 2004 May 1;100(9):1918-27. doi: 10.1002/cncr.20190. Cancer. 2004. PMID: 15112273
-
Gene expression profiling and non-small-cell lung cancer: where are we now?Clin Lung Cancer. 2009 May;10(3):168-73. doi: 10.3816/CLC.2009.n.023. Clin Lung Cancer. 2009. PMID: 19443336 Review.
-
Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.Expert Rev Mol Diagn. 2007 Jan;7(1):77-86. doi: 10.1586/14737159.7.1.77. Expert Rev Mol Diagn. 2007. PMID: 17187486 Review.
Cited by
-
Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway.Clin Transl Med. 2021 Sep;11(9):e478. doi: 10.1002/ctm2.478. Clin Transl Med. 2021. PMID: 34586722 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
